Page 9
Industry Dive, Inc newsletters
Biopharma Dive Newsletter 25 May 2019
BROUGHT TO YOU BY — BioPharma Dive Brand Studio
Optimize Your Workflows with Better Data
How much data is too much? Many biotechs struggle with data overload, which can be detrimental in today’s competitive pharma landscape. Learn how new technologies can optimize your usage.
BioPharma Dive’s Top News | Weekender | May 25, 2019
Main Headline: Novartis gene therapy approved, but will come at cost of more than $2 million
Other headlines
5 novel immuno-oncology targets to know before ASCO
Novartis looking earlier for deals as biotech valuations stay high
SPONSORED CONTENT BY BIOPHARMA DIVE BRAND STUDIO
How do you choose the right CDMO partner?
UK charity sells Keytruda rights for $1.3B
Merck puts $1B more into oncology, with kidney cancer a focus
No news is bad news for Tocagen
UPCOMING EVENT
How to Choose the Best Partner for Your Biologic Development and Manufacturing | June 11, 2019 | Webinar 2 pm ET
Read all the above plus more via this button
Don’t forget that I subscribe for the newsletters that I share
Biopharma Dive Newsletter 14 May 2019
Reach New Heights with Catalent Biologics at BIO
Catalent to Acquire Gene Therapy Leader Paragon Bioservices
Catalent Biologics has entered into an agreement to acquire Paragon Bioservices, a leading viral vector development and manufacturing partner focused on the rapidly expanding gene therapy market.
Read all about the deal via the newsletter button link below to the Biopharma Newsletter 14 May 2019
WEBINAR: Planning Successful Launches of Complex Drug Products
Developing and bringing a new drug to market is a long, expensive and uncertain process. It’s even more complicated when it comes to complex products such as biologics.
Watch the webinar through clicking the link below to the Biopharma Newsletter 14 May 2019
Catalent Pharma Solutions respects your privacy.
Links to third party sites are provided as a convenience only. Catalent makes no representation or warranty about the technology, security or any content available at these sites. Links are not intended to imply Catalent’s affiliation or endorsement or the website, its owner(s) or the content.
© 2019, Catalent Pharma Solutions, Inc. 14 Schoolhouse Road, Somerset, NJ 08873. All rights reserved.
Read the above and get access to read more via this button
BioPharma Dive Weekender | May 11, 2019
Headlines
‘Stay tuned.’ Allergan CEO vows decisive action amid investor anger
Yet Brent Saunders offered few specifics on a path forward for Allergan, which recently staved off a challenge from activist investor Appaloosa.
Roche risdiplam data heats up SMA rivalry with Novartis
The oral agent looks like it could give gene therapy Zolgensma a run for its money.
Catalyst dives as FDA approves rival’s rare disease drug
Jacobus Pharmaceutical’s Ruzurgi is cleared for a different age range than Catalyst’s Firdapse, yet investors appear concerned about off-label use eroding the latter’s business.
SPONSORED CONTENT BY BIOPHARMA DIVE BRAND STUDIO
FDA guidance to using eConsent in clinical trials
Learn more about the FDA’s support of eConsent and where the future of biopharma trial consent is headed in our webinar. Watch now.
Drugmakers will soon be required to disclose prices in TV ads
Forcing pharma’s hand, the Trump administration finalized a proposal requiring list prices in DTC advertising, inviting a possible legal challenge from industry.
Pfizer to buy Therachon for $340M, taking on BioMarin, Ascendis
Therachon has advanced an experimental treatment for dwarfism through Phase 1 testing. Pfizer said they will take it from there.
Read the above news via this button link to the newsletter
BioPharma Dive is a product of Industry Dive, Inc.. 1575 Eye St NW, 4th Floor, Washington, DC 20005. We value your privacy. We won’t share your email address with anyone else without your permission.
Healthcare Dive weekender June 1, 2019
DOJ loses bid to change contours of CVS-Aetna settlement hearing
Provider groups slam rate setting in House surprise billing draft legislation
WannaCry malware still hitting healthcare organizations
Most hospitals don’t meet Leapfrog maternity care standards
Half of hospital boards lack succession plan
Read the articles above and more via the button link below
Healthcare Dive weekender May 25, 2019
BROUGHT TO YOU BY — IBM
Pinpoint Actionable Insights To Make Confident Decisions
Learn how better insights lead to confident decision making and see how IBM Watson Health is elevating performance. Read the case study.
Main Headline: UnitedHealth named most valuable healthcare brand
Other headlines
5 state AGs push judge to approve CVS-Aetna merger agreement
Q&A: Ascension’s chief community impact officer on providing care outside the hospital
No improvement in patient access to online health records, ONC finds
Private payers cover more than 40% of drug costs
UPCOMING EVENTS
The 4th Annual RISE Quality Leadership Summit – Qualipalooza
June 27, 2019 – June 28, 2019 | Orlando, FL
Read the articles above and more via the button link below
Don’t forget that I subscribe for the newsletters that I share
Healthcare Dive is a product of Industry Dive, Inc.. 1575 Eye St NW, 4th Floor, Washington, DC 20005. We value your privacy. We won’t share your email address with anyone else without your permission.
MedTech Dive Weekender June 1, 2019
| Vertex chooses its cystic fibrosis future Following positive late-stage readouts for two combination regimens, Vertex has selected the triplet it intends to file with regulators later this year. |
| Turning Point makes push to outdo Pfizer, Roche in targeted cancer therapy Fresh off an IPO, the San Diego biotech unveiled data on ASCO’s first day for repotrectinib, its challenger to Xalkori and entrectinib in a rare type of lung cancer. |
| As ASCO begins, Iovance shows progress with cancer cell therapy The biotech’s therapy, which uses tumor-infiltrating lymphocytes, has spurred responses in some patients with advanced melanoma and cervical cancer. |
| SPONSORED CONTENT BY LEE INDUSTRIES How to choose the right system for high-viscosity mixing This solution delivers fast, consistent mixing via double-motion scraped-surface agitation, counter-rotating mixing bars and a high-shear mixing head.Get the Guide. |
| PE firm nabs Vibalogics, banking on demand for complex viral products The deal brings 50 employees and a 27,000-square-foot manufacturing facility in Germany under the ownership of Ampersand Capital Partners. |
| Mitsubishi pulls EU application for ALS drug, citing ‘unwarranted’ data request Regulators had concerns that data from a key study that has helped Radicava in other markets isn’t strong enough to warrant approval in the bloc. |
Four steps to choosing the right CDMO partner In our webinar, hear from what industry experts believe are the four most important steps you can follow to assess and select the CDMO that fits your organization’s needs and aligns with your goals.
Read the articles above and more via the button link below
MedTech Dive Weekender May 25, 2019
BROUGHT TO YOU BY — PTC
Maximize medical device uptime with IoT
Explore how IoT technology is helping medical device manufacturers maximize device uptime by providing proactive service. Download the guide
Main headline: J&J’s Auris unveils early results on Monarch robot for lung procedures
Other headlines
Biotronik stent bests Medtronic in study of small-vessel lesions
Cook lands rights to sell single-use duodenoscope in US
LifeScan deal challenges Abbott, Dexcom for CGM market
Integra LifeSciences recall draws Class I label from FDA
Read the articles above and more via the button link below
Don’t forget I subscribe to all the newsletters that I share
Follow Medtech Dive on Twitter
Medtech Dive 14 May 2019
Brought to you by
ZS Associates
Medtech Leaders Discuss Vertical Integration and Hospital Centricity | Medtech Dive 14 May 2019
Strategic vertical integration can offer medtech companies a new path forward within a fluctuating healthcare landscape
Opening lines
Access this newsletter via this button link
MedTech Dive is a product of Industry Dive, Inc. 1575 Eye St NW, Suite 400, Washington, DC 20005
Please remember that I subscribe to all the newsletters included in this magazine
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13
Page 9
2 replies on “#ChronicIllnessVoice | Pharma / Science / Tech / Digital / AI | A mix of news, events and Resources”
[…] #ChronicIllnessVoice | Pharma / Science / Tech / Digital / AI | A mix of news, events and Resources […]
[…] #ChronicIllnessVoice | Pharma / Science / Tech / Digital / AI | A mix of news, events and Resources […]